The COVID‐19 epidemic in Madagascar: clinical description and laboratory results of the first wave, march‐september 2020 - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Influenza and Other Respiratory Viruses Year : 2021

The COVID‐19 epidemic in Madagascar: clinical description and laboratory results of the first wave, march‐september 2020

Abstract

Background: Following the first detection of SARS-CoV-2 in passengers arriving from Europe on 19 March 2020, Madagascar took several mitigation measures to limit the spread of the virus in the country. Methods: Nasopharyngeal and/or oropharyngeal swabs were collected from travel- lers to Madagascar, suspected SARS-CoV-2 cases and contact of confirmed cases. Swabs were tested at the national reference laboratory using real-time RT-PCR. Data collected from patients were entered in an electronic database for subsequent sta- tistical analysis. All distribution of laboratory-confirmed cases were mapped, and six genomes of viruses were fully sequenced. Results: Overall, 26,415 individuals were tested for SARS-CoV-2 between 18 March and 18 September 2020, of whom 21.0% (5,553/26,145) returned positive. Among laboratory-confirmed SARS-CoV-2–positive patients, the median age was 39 years (IQR: 28-52), and 56.6% (3,311/5,553) were asymptomatic at the time of sampling. The probability of testing positive increased with age with the highest adjusted odds ratio of 2.2 [95% CI: 1.9-2.5] for individuals aged 49 years and more. Viral strains sequenced belong to clades 19A, 20A and 20B indicative of several independent in- troduction of viruses. Conclusions Our study describes the first wave of the COVID-19 in Madagascar. Despite early strategies in place Madagascar could not avoid the introduction and spread of the virus. More studies are needed to estimate the true burden of disease and make public health recommendations for a better preparation to another wave.
Fichier principal
Vignette du fichier
Randremanana et al. - 2021 - The COVID-19 epidemic in Madagascar clinical desc.pdf (1.08 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

pasteur-03221746 , version 1 (09-05-2021)

Licence

Attribution

Identifiers

Cite

Rindra Vatosoa Randremanana, Soa-Fy Andriamandimby, Jean Marius Rakotondramanga, Norosoa Harline Razanajatovo, Reziky Tiandraza Mangahasimbola, et al.. The COVID‐19 epidemic in Madagascar: clinical description and laboratory results of the first wave, march‐september 2020. Influenza and Other Respiratory Viruses, 2021, ⟨10.1111/irv.12845⟩. ⟨pasteur-03221746⟩
42 View
71 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More